Leadership Overview
Edwards Lifesciences has 7 executives leading key functions including finance, sales, human resources, supply chain, strategy, and surgical structural heart.
Driven by a commitment to patient well-being, Edwards Lifesciences is dedicated to advancing medical technologies for structural heart disease and critical care monitoring, aiming to improve and save lives globally.
Driven by a commitment to patient well-being, Edwards Lifesciences is dedicated to advancing medical technologies for structural heart disease and critical care monitoring, aiming to improve and save lives globally.
Leadership Roles at Edwards Lifesciences
Doretta Mistras - Chief Financial Officer
Doretta Mistras, the Chief Financial Officer at Edwards Lifesciences, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Mistras ensures robust financial health and compliance across the organization. This leadership role involves managing investor relations and capital allocation to support the company's growth initiatives in structural heart disease and critical care technologies. By optimizing financial strategies, Doretta Mistras directly contributes to the company's ability to fund research and development for life-changing therapies. The Chief Financial Officer's oversight extends to managing financial risks and identifying opportunities for enhanced profitability, aligning fiscal discipline with the company's mission to improve patient outcomes. This executive drives financial performance, ensuring resources are effectively deployed to advance Edwards Lifesciences' market position and operational efficiency.
Miyuki Ogushi - Representative Executive Officer and President and
Miyuki Ogushi, the Representative Executive Officer and President and at Edwards Lifesciences, holds a pivotal leadership position overseeing broad operational and strategic mandates. Directing key business functions and driving corporate initiatives, Ogushi ensures alignment with the company's core mission of advancing medical technologies for structural heart disease and critical care monitoring. This executive's responsibilities encompass fostering innovation and ensuring the effective execution of strategies aimed at improving patient outcomes globally. By providing executive leadership, Miyuki Ogushi directly contributes to the company's sustained success and its commitment to delivering life-changing therapies. The Representative Executive Officer and President and's role is critical in navigating complex market dynamics and championing the company's values. Ogushi's leadership ensures Edwards Lifesciences continues to be a leader in cardiovascular solutions.
Veronica Shin - Chief Sales Officer (CSO)
Veronica Shin, the Chief Sales Officer (CSO) at Edwards Lifesciences, spearheads all global sales strategies and execution. Directing the sales force, Shin focuses on expanding market penetration for the company's innovative solutions in structural heart disease and critical care monitoring. This role involves cultivating key relationships with healthcare providers and distributors worldwide, ensuring the effective delivery of life-changing therapies. By driving sales performance, Veronica Shin directly impacts revenue generation and market share growth. The Chief Sales Officer's responsibilities include developing sales forecasts, managing sales territories, and implementing performance metrics to achieve ambitious commercial objectives. Shin's leadership ensures that Edwards Lifesciences' advanced cardiovascular technologies reach the patients who need them most, reinforcing the company's commitment to improving patient outcomes through dedicated commercial efforts.
Orly Bar - Chief of Staff & Director, Human Resources
Orly Bar, the Chief of Staff & Director, Human Resources at Edwards Lifesciences, provides strategic support to executive leadership and directs all human resources functions. Overseeing talent acquisition, employee development, and organizational culture, Bar ensures a high-performing workforce aligned with the company's mission. This dual role involves managing key strategic initiatives and fostering an environment that supports innovation in medical technology. By optimizing HR processes, Orly Bar directly contributes to employee engagement and retention, critical for advancing Edwards Lifesciences' goals in structural heart disease and critical care. The Chief of Staff & Director, Human Resources's purview includes implementing policies that support the company's dedication to improving patient outcomes through its dedicated team. Bar's leadership ensures operational efficiency and strategic alignment across all departments.
Joseph Nuzzolese - Corporate Vice President, Global Supply Chain & Quality
Joseph Nuzzolese, the Corporate Vice President, Global Supply Chain & Quality at Edwards Lifesciences, directs the end-to-end supply chain operations and ensures stringent quality standards. Overseeing procurement, manufacturing logistics, and distribution, Nuzzolese guarantees the reliable delivery of critical medical technologies worldwide. This leadership position is vital for maintaining the integrity and availability of Edwards Lifesciences' products, particularly those for structural heart disease and critical care monitoring. By optimizing supply chain efficiency and upholding rigorous quality control, Joseph Nuzzolese directly supports the company's mission to improve patient outcomes. The Corporate Vice President's focus on quality assurance ensures that all therapies meet the highest safety and efficacy standards. Nuzzolese's strategic management of global operations underpins the company's ability to consistently provide life-changing solutions.
Donald Bobo - Corporate Vice President, Strategy & Corporate Development
Donald Bobo, the Corporate Vice President, Strategy & Corporate Development at Edwards Lifesciences, architects the company's long-term strategic vision and oversees key corporate development initiatives. Directing market analysis, strategic planning, and merger and acquisition activities, Bobo identifies opportunities to enhance Edwards Lifesciences' leadership in structural heart disease and critical care monitoring. This role is crucial for driving innovation and expanding the company's portfolio of life-changing therapies. By shaping strategic direction, Donald Bobo directly contributes to the company's sustained growth and market impact. The Corporate Vice President's responsibilities include evaluating potential partnerships and investments that align with the mission to improve patient outcomes. Bobo's strategic foresight ensures Edwards Lifesciences remains at the forefront of cardiovascular medical technology.
Daveen Chopra - Corporate Vice President, Surgical Structural Heart
Daveen Chopra, the Corporate Vice President, Surgical Structural Heart at Edwards Lifesciences, leads the strategic direction and commercialization efforts for the surgical structural heart portfolio. Overseeing product development, market access, and physician engagement, Chopra drives the adoption of advanced therapies for cardiovascular conditions. This executive role is central to advancing Edwards Lifesciences' mission of improving patient outcomes through innovative surgical solutions. By focusing on the surgical structural heart segment, Daveen Chopra directly enhances the company's ability to address complex cardiac needs. The Corporate Vice President's leadership ensures close collaboration with surgeons and healthcare teams to refine and deliver life-changing treatments. Chopra's expertise guides the expansion of surgical options, reinforcing Edwards Lifesciences' commitment to pioneering cardiovascular care.
Explore Leadership Teams in Manufacturing
GE HealthCare is a global medical technology and healthcare solutions organization with a long heritage of innovation in the health care industry. The company is headquartered in the United States and has cultivated a reputation as a leading provider of technologies and services that support the diagnosis, treatment, and monitoring of patients across a wide range of clinical settings. GE HealthCare develops and delivers a broad portfolio of advanced products that includes imaging systems, patient monitoring tools, ultrasound equipment, ancillary devices used in interventional care, and pharmaceutical diagnostics that help clinicians visualize internal biological structures. The organization operates at the center of the healthcare ecosystem, aiming to improve productivity, expand access, and enhance outcomes in clinical environments by combining medical devices with digital solutions and services. Its offerings are designed to assist physicians and other healthcare professionals in delivering precise, timely, and actionable information, which supports key clinical decisions from initial screening through therapy and ongoing care. GE HealthCares technologies extend from sophisticated imaging platforms and visualization systems to remote patient monitoring solutions powered by data analytics and cloud-enabled tools.
Company Leadership
BF
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PX SLIM, and Velocity brands; aspiration based thrombectomy systems and accessory devices under the Penumbra System brand; and revascularization device for mechanical thrombectomy under the 3D brand. Penumbra was founded in 2004 and is headquartered in Alameda, California.
Company Leadership
JB
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
CB
Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care and surgical and sports medicine markets.
Company Leadership PL
PB
MS
Frequently Asked Questions Regarding Edwards Lifesciences Top Executives and Leadership Team
Unlock more people and company data
